Drug Type AAV based gene therapy |
Synonyms Lysosomal storage disease3 therapy(Belief BioMed) |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Belief BioMed, Inc.Startup |
Active Organization Belief BioMed, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lysosomal Storage Diseases | Preclinical | CN | Belief BioMed, Inc.Startup | 30 Nov 2022 |